{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:04:14Z","timestamp":1772136254837,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Around ten million people are infected with HTLV-1 worldwide, and 1\u20134% develop HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), characterized by an important degeneration of the spinal cord, which can lead to death. Distinct HLA alleles have been associated with either HAM\/TSP susceptibility or protection. However, these HLA alleles set may change according to the population studied. Brazil is the second country in the number of HTLV-1-infected people and there are few reports addressing the HLA influence on HTLV-1 infection as well as on disease outcome. The objective of this study was to evaluate the influence of HLA alleles as a risk factor for HAM\/TSP and the proviral load (PVL) levels, clinical progression, and death outcomes in an admixed Brazilian population. The HLA-A, -B, -C, and -DRB1 were genotyped in 375 unrelated HTLV-1-infected individuals divided into asymptomatic carriers (AC) (n\u2009=\u2009165) and HAM\/TSP (n\u2009=\u2009210) in a longitudinal cohort from 8 to 22\u00a0years of follow-up. Because locus B deviated from Hardy\u2013Weinberg Equilibrium for the study groups, the results represented for HLA-B alleles were inconclusive. The alleles HLA-A*68 and -C*07 were related to HAM\/TSP risk in multivariate analysis. The alleles HLA-A*33, and -A*36 were associated with protection against disease progression in HAM\/TSP patients, while -C*12, -C*14, and -DRB1*08 were associated with increased risk of death. In the AC group, the presence of, -C*06 and -DRB1*15 alleles influenced an increased PVL, in an adjusted linear regression model, while -A*30, -A*34, -C*06, -C*17 and -DRB1*09 alleles were associated with increased PVL in HAM\/TSP group compared to HAM\/TSP individuals not carrying these alleles. All these alleles were also related to increased PVL associated with clinical progression outcome. Increased PVL associated with the death outcome was linked to the presence of HLA-A*30. PVL has been associated with HLA, and several alleles were related in AC and HAM\/TSP patients with or without interacting with clinical progression outcomes. Understanding the prognostic value of HLA in HAM\/TSP pathogenesis can provide important biomarkers tools to improve clinical management and contribute to the discovery of new therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41598-023-34757-w","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:01:52Z","timestamp":1683784912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) population"],"prefix":"10.1038","volume":"13","author":[{"given":"Doris","family":"Schor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Crist\u00f3v\u00e3o","family":"Porto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Henrique","family":"Roma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Castro-Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Paula","family":"Villela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abelardo Q. C.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gl\u00f3ria Bonecini-Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"34757_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. & Uchino, H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50, 481\u2013492 (1977).","journal-title":"Blood"},{"key":"34757_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain, A. et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407\u2013410 (1985).","journal-title":"Lancet"},{"key":"34757_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame, M. et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031\u20131032 (1986).","journal-title":"Lancet"},{"key":"34757_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain, A. & Cassar, O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3, 388 (2012).","journal-title":"Front. Microbiol."},{"key":"34757_CR5","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","volume":"1","author":"CRM Bangham","year":"2015","unstructured":"Bangham, C. R. M., Araujo, A., Yamano, Y. & Taylor, G. P. HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat. Rev. Dis. Primers. 1, 15012 (2015).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"34757_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","volume":"3","author":"Y Yamano","year":"2012","unstructured":"Yamano, Y. & Sato, T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis. Front. Microbiol. 3, 389 (2012).","journal-title":"Front. Microbiol."},{"key":"34757_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","volume":"69","author":"NM Castro","year":"2007","unstructured":"Castro, N. M. et al. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: Evidence of urinary manifestations in large group of HTLV-I carriers. Urology 69, 813\u2013818 (2007).","journal-title":"Urology"},{"key":"34757_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bjid.2019.04.002","volume":"23","author":"RH Rathsam-Pinheiro","year":"2019","unstructured":"Rathsam-Pinheiro, R. H. et al. Revisiting Keratoconjunctivitis sicca associated with Human T-Cell Lymphotropic Virus Type 1: prevalence, clinical aspects and proviral load. Braz. J. Infect. Dis. 23, 95\u2013101 (2019).","journal-title":"Braz. J. Infect. Dis."},{"key":"34757_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0306-9877(93)90111-3","volume":"41","author":"S Ijichi","year":"1993","unstructured":"Ijichi, S. et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM\/TSP. Med. Hypotheses. 41, 542\u2013547 (1993).","journal-title":"Med. Hypotheses."},{"key":"34757_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-0039.1991.tb01877.x","volume":"37","author":"Y Nishimura","year":"1991","unstructured":"Nishimura, Y. et al. A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese. Tissue Antigens 37, 230\u2013231 (1991).","journal-title":"Tissue Antigens"},{"key":"34757_CR11","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery, K. J. et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. U S A. 96, 3848\u20133853 (1999).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"34757_CR12","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","volume":"165","author":"KJ Jeffery","year":"2000","unstructured":"Jeffery, K. J. et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165, 7278\u20137284 (2000).","journal-title":"J. Immunol."},{"key":"34757_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004199118","volume":"118","author":"M Penova","year":"2021","unstructured":"Penova, M. et al. Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population. Proc. Natl. Acad. Sci. U S A. 118, e2004199118 (2021).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"34757_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1365-2249.1998.00497.x","volume":"111","author":"B Kitze","year":"1998","unstructured":"Kitze, B. et al. Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. Clin. Exp. Immunol. 111, 278\u2013285 (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"34757_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1099\/vir.0.80509-0","volume":"86","author":"AH Sabouri","year":"2005","unstructured":"Sabouri, A. H. et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J. Gen. Virol. 86, 773\u2013781 (2005).","journal-title":"J. Gen. Virol."},{"key":"34757_CR16","first-page":"94","volume":"4","author":"H Rafatpanah","year":"2007","unstructured":"Rafatpanah, H. et al. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection. Iran J. Immunol. 4, 94\u2013100 (2007).","journal-title":"Iran J. Immunol."},{"key":"34757_CR17","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00415-013-7014-z","volume":"260","author":"A Trevi\u00f1o","year":"2013","unstructured":"Trevi\u00f1o, A. et al. Association between HLA alleles and HAM\/TSP in individuals infected with HTLV-1. J. Neurol. 260, 2551\u20132555 (2013).","journal-title":"J. Neurol."},{"key":"34757_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12977-020-00536-y","volume":"17","author":"P Benencio","year":"2020","unstructured":"Benencio, P. et al. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP) in patients living in Argentina. Retrovirology 17, 29 (2020).","journal-title":"Retrovirology"},{"key":"34757_CR19","first-page":"264","volume":"16","author":"M Taghaddosi","year":"2013","unstructured":"Taghaddosi, M. et al. Association between HLA Class I Alleles and Proviral Load in HTLV-I associated myelopathy\/tropical spastic paraperesis (HAM\/TSP) patients in Iranian population. Iran. J. Basic Med. Sci. 16, 264\u2013267 (2013).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"34757_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2016.11.009","volume":"228","author":"H Tarokhian","year":"2017","unstructured":"Tarokhian, H. et al. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. Virus Res. 228, 1\u20136 (2017).","journal-title":"Virus Res."},{"key":"34757_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jmv.21675","volume":"82","author":"M Talledo","year":"2010","unstructured":"Talledo, M. et al. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy\/tropical spastic paraparesis in Peruvian HTLV-1-infected patients. J. Med. Virol. 82, 460\u2013466 (2010).","journal-title":"J. Med. Virol."},{"key":"34757_CR22","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.1016\/j.ijid.2010.05.020","volume":"14","author":"R Deschamps","year":"2010","unstructured":"Deschamps, R. et al. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population. Int. J. Infect. Dis. 14, e986-990 (2010).","journal-title":"Int. J. Infect. Dis."},{"key":"34757_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1046\/j.1365-2141.2003.04711.x","volume":"123","author":"DM Borducchi","year":"2003","unstructured":"Borducchi, D. M. et al. Human leucocyte antigen and human T-cell lymphotropic virus type 1 associated diseases in Brazil. Br. J. Haematol. 123, 954\u2013955 (2003).","journal-title":"Br. J. Haematol."},{"key":"34757_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-008-0096-z","volume":"198","author":"BC Catalan-Soares","year":"2009","unstructured":"Catalan-Soares, B. C. et al. HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med. Microbiol. Immunol. 198, 1\u20133 (2009).","journal-title":"Med. Microbiol. Immunol."},{"key":"34757_CR25","unstructured":"Perfil Gen\u00f4mico do REDOME\/REREME [Internet]. Rede Brasil de Imunogen\u00e9tica. [cited 2022 Feb 17]. Available from: http:\/\/imunogenetica.org\/resultados\/perfil-genomico-do-redome-rereme\/."},{"key":"34757_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3389\/fmicb.2019.01101","volume":"10","author":"M Saito","year":"2019","unstructured":"Saito, M. Association between HTLV-1 genotypes and risk of HAM\/TSP. Front. Microbiol. 10, 1101 (2019).","journal-title":"Front. Microbiol."},{"key":"34757_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41525-020-00149-6","volume":"5","author":"CS Rocha","year":"2020","unstructured":"Rocha, C. S., Secolin, R., Rodrigues, M. R., Carvalho, B. S. & Lopes-Cendes, I. The Brazilian Initiative on Precision Medicine (BIPMed): Fostering genomic data-sharing of underrepresented populations. NPJ Genom. Med. 5, 42 (2020).","journal-title":"NPJ Genom. Med."},{"key":"34757_CR28","first-page":"5","volume":"1","author":"AQC Araujo","year":"2019","unstructured":"Araujo, A. Q. C. Neurologic complications of HTLV-1: A review. Rev. Bras. Neurol. 1, 5\u201310 (2019).","journal-title":"Rev. Bras. Neurol."},{"key":"34757_CR29","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3390\/pathogens9010025","volume":"9","author":"RMN Marcusso","year":"2019","unstructured":"Marcusso, R. M. N. et al. Dichotomy in fatal outcomes in a large cohort of people living with HTLV-1 in S\u00e3o Paulo Brazil. Pathogens 9, E25 (2019).","journal-title":"Pathogens"},{"key":"34757_CR30","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1136\/jnnp.2009.191239","volume":"81","author":"F Martin","year":"2010","unstructured":"Martin, F., Fedina, A., Youshya, S. & Taylor, G. P. A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK. J. Neurol. Neurosurg. Psychiatry. 81, 1336\u20131340 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"34757_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.humimm.2016.04.017","volume":"77","author":"C Ravazzi-Gauch","year":"2016","unstructured":"Ravazzi-Gauch, C., Bajay, M. M., Caldas, H. C. & Abbud-Filho, M. HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates. Hum. Immunol. 77, 464\u2013469 (2016).","journal-title":"Hum. Immunol."},{"key":"34757_CR32","unstructured":"Silva, N.D.S.B., Souza, A.S., Andrade, H.S., Pereira, R.N., Castro, C.F.B., & Vince, N., et al. Immunogenetics of HLA-B: SNP, allele, and haplotype diversity in populations from different continents and ancestry backgrounds. HLA (2023)."},{"key":"34757_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1086\/510679","volume":"44","author":"MTT Silva","year":"2007","unstructured":"Silva, M. T. T. et al. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy\/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin. Infect. Dis. 44, 689\u2013692 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"34757_CR34","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1086\/595855","volume":"48","author":"MT Silva","year":"2009","unstructured":"Silva, M. T. et al. Isolated bladder dysfunction in human T lymphotropic virus type 1 infection. Clin. Infect. Dis. 48, e34-36 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"34757_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/infdis\/166.4.943","volume":"166","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki, M. et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J. Infect. Dis. 166, 943\u2013944 (1992).","journal-title":"J. Infect. Dis."},{"key":"34757_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2020.00388","volume":"11","author":"K Kamoi","year":"2020","unstructured":"Kamoi, K. HTLV-1 in ophthalmology. Front. Microbiol. 11, 388 (2020).","journal-title":"Front. Microbiol."},{"key":"34757_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599558","volume":"11","author":"JJW Kuiper","year":"2020","unstructured":"Kuiper, J. J. W. & Venema, W. J. HLA-A29 and Birdshot Uveitis: Further Down The Rabbit Hole. Front. Immunol. 11, 599558 (2020).","journal-title":"Front. Immunol."},{"key":"34757_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4274\/tjo.galenos.2018.53896","volume":"49","author":"M \u0130nan\u00e7","year":"2019","unstructured":"\u0130nan\u00e7, M., \u015eim\u015fek, M. & \u00c7akar \u00d6zdal, M. P. Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center. Turk. J. Ophthalmol. 49, 10\u201314 (2019).","journal-title":"Turk. J. Ophthalmol."},{"key":"34757_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023469","volume":"6","author":"W Song","year":"2011","unstructured":"Song, W. et al. Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population. PLoS ONE 6, e23469 (2011).","journal-title":"PLoS ONE"},{"key":"34757_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108990","volume":"238","author":"S Hern\u00e1ndez-Do\u00f1o","year":"2022","unstructured":"Hern\u00e1ndez-Do\u00f1o, S. et al. Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas Mexico. Clin. Immunol. 238, 108990 (2022).","journal-title":"Clin. Immunol."},{"key":"34757_CR41","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s11033-013-2509-3","volume":"40","author":"D Rey","year":"2013","unstructured":"Rey, D. et al. HLA genetic profile of Mapuche (Araucanian) Amerindians from Chile. Mol. Biol. Rep. 40, 4257\u20134267 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"34757_CR42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0198-8859(01)00297-X","volume":"62","author":"Z Layrisse","year":"2001","unstructured":"Layrisse, Z. et al. Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range. Hum. Immunol. 62, 992\u20131000 (2001).","journal-title":"Hum. Immunol."},{"key":"34757_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241282","volume":"15","author":"RM Single","year":"2020","unstructured":"Single, R. M. et al. Demographic history and selection at HLA loci in Native Americans. PLoS ONE 15, e0241282 (2020).","journal-title":"PLoS ONE"},{"key":"34757_CR44","first-page":"3830104","volume":"1","author":"TG Biberg-Salum","year":"2018","unstructured":"Biberg-Salum, T. G. et al. HLA-C alleles and cytomegalovirus retinitis in Brazilian patients with AIDS. J. Ophthalmol. 1, 3830104 (2018).","journal-title":"J. Ophthalmol."},{"key":"34757_CR45","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1128\/jvi.66.4.2288-2295.1992","volume":"66","author":"A Gessain","year":"1992","unstructured":"Gessain, A., Gallo, R. C. & Franchini, G. Low degree of human T-cell leukemia\/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J. Virol. 66, 2288\u20132295 (1992).","journal-title":"J. Virol."},{"key":"34757_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093374","volume":"9","author":"R Pess\u00f4a","year":"2014","unstructured":"Pess\u00f4a, R. et al. Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology. PLoS ONE 9, e93374 (2014).","journal-title":"PLoS ONE"},{"key":"34757_CR47","doi-asserted-by":"publisher","first-page":"104166","DOI":"10.1016\/j.meegid.2019.104166","volume":"79","author":"THA Ara\u00fajo","year":"2020","unstructured":"Ara\u00fajo, T. H. A. et al. Complete genome sequence of human T-cell lymphotropic type 1 from patients with different clinical profiles, including infective dermatitis. Infect. Genet. Evol. 79, 104166 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"34757_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12977-019-0504-z","volume":"16","author":"PV Afonso","year":"2019","unstructured":"Afonso, P. V., Cassar, O. & Gessain, A. Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes. Retrovirology 16, 39 (2019).","journal-title":"Retrovirology"},{"key":"34757_CR49","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1073\/pnas.1504447112","volume":"112","author":"FSG Kehdy","year":"2015","unstructured":"Kehdy, F. S. G. et al. Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc. Natl. Acad. Sci. U S A. 112, 8696\u20138701 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"34757_CR50","doi-asserted-by":"publisher","first-page":"13900","DOI":"10.1038\/s41598-019-50362-2","volume":"9","author":"R Secolin","year":"2019","unstructured":"Secolin, R. et al. Distribution of local ancestry and evidence of adaptation in admixed populations. Sci. Rep. 9, 13900 (2019).","journal-title":"Sci. Rep."},{"key":"34757_CR51","doi-asserted-by":"publisher","first-page":"1091269","DOI":"10.3389\/fgene.2023.1091269","volume":"14","author":"TC De Oliveira","year":"2023","unstructured":"De Oliveira, T. C., Secolin, R. & Lopes-Cendes, I. A review of ancestrality and admixture in Latin America and the caribbean focusing on native American and African descendant populations. Front Genet. 14, 1091269 (2023).","journal-title":"Front Genet."},{"key":"34757_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.rdc.2020.01.002","volume":"46","author":"H Fahed","year":"2020","unstructured":"Fahed, H., Mauro, D., Ciccia, F. & Ziade, N. R. What does human leukocyte antigen B27 have to do with spondyloarthritis?. Rheum Dis Clin North Am. 46, 225\u2013239 (2020).","journal-title":"Rheum Dis Clin North Am."},{"key":"34757_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245541","volume":"16","author":"S Becart","year":"2021","unstructured":"Becart, S., Whittington, K. B., Prislovsky, A., Rao, N. L. & Rosloniec, E. F. The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses. PLoS ONE 16, e0245541 (2021).","journal-title":"PLoS ONE"},{"key":"34757_CR54","unstructured":"Osame, M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. Human Retrovirology: HTLV. Raven; p. 191\u20137 (1990)."},{"key":"34757_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/jnnp.2004.035709","volume":"76","author":"MA Lima","year":"2005","unstructured":"Lima, M. A., Bica, R. B. S. & Ara\u00fajo, A. Q. C. Gender influence on the progression of HTLV-I associated myelopathy\/tropical spastic paraparesis. J. Neurol. Neurosurg. Psychiatry. 76, 294\u2013296 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"34757_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","volume":"46","author":"M Bunce","year":"1995","unstructured":"Bunce, M. et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355\u2013367 (1995).","journal-title":"Tissue Antigens"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34757-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:02:05Z","timestamp":1683828125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34757-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1697475\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-1697475\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7659"}}